Abstract:Background/Aims: Dysregulated expression of WW domain-binding protein 2 (WBP2) is associated with poor prognosis in ER+ breast cancer patients. However, its role in triple negative breast cancer (TNBC) has not been previously assessed. Therefore, we aimed to elucidate the functional mechanism of WBP2 in TNBC cells. Methods: qRT-PCR, western blotting, and immunohistochemical staining were used to evaluate WBP2 expression in TNBC patient tumors and cell lines. HCC1937 and MDA-MB-231 cells transiently transfected with WBP2 small interfering RNA (siRNA), miR-613 mimics, or miR-613 inhibitors were subject to assays for cell viability, apoptosis and cell cycle distribution. Co-immunoprecipitation, western blotting or qRT-PCR were employed to monitor changes in signaling pathway-related genes and proteins. Luciferase assays were performed to assess whether WBP2 is a direct target of miR-613. The effect of miR-613 on tumor growth was assessed in vivo using mouse xenograft models. Results: The expression of WBP2 was upregulated in TNBC tissues and cells. Expression of WBP2 was significantly correlated with Ki67 in TNBC patients. Knockdown of WBP2 inhibited cellular proliferation, promoted apoptosis, and induced cell cycle arrest of TNBC cells. miR-613 directly bound to the 3’-untranslated region (3’-UTR) of WBP2 and regulated the expression of WBP2. Moreover, miR-613 reduced the expression of WBP2 and suppressed tumor growth of TNBC cells in vivo. Knockdown of WBP2 inhibited YAP transcription and the EGFR/PI3K/Akt signaling pathway in TNBC cells, and these effects were reversed by inhibition of miR-613. Conclusion: WBP2 overexpression is associated with the poor prognosis of TNBC patients and the miR-613-WBP2 axis represses TNBC cell growth by inactivating YAP-mediated gene expression and the EGFR/PI3K/Akt signaling pathway.

Inhibition of WWP 2 Suppresses Proliferation , and Induces G 1 Cell Cycle Arrest and Apoptosis in Liver Cancer Cells

Silencing of WWP2 Inhibits Adhesion, Invasion, and Migration in Liver Cancer Cells

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

Knockdown of Wwp1 Inhibits Growth and Induces Apoptosis in Hepatoma Carcinoma Cells Through the Activation of Caspase3 and P53

WWOX Suppresses Cell Growth and Induces Cell Apoptosis Via Inhibition of P38 Nuclear Translocation in Cholangiocarcinoma

PWP1 is overexpressed in hepatocellular carcinoma and facilitates liver cancer cell proliferation

Comprehensive Analysis of Ubiquitin‐specific Protease 1 Reveals Its Importance in Hepatocellular Carcinoma

WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer

WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression

LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity

WWP1 upregulation predicts poor prognosis and promotes tumor progression by regulating ubiquitination of NDFIP1 in intrahepatic cholangiocarcinoma

Targeting WDxR Motif Reprograms Immune Microenvironment and Inhibits Hepatocellular Carcinoma Progression.

High Expression of WWP1 Predicts Poor Prognosis and Associates with Tumor Progression in Human Colorectal Cancer.

WWP2 Regulates Proliferation of Gastric Cancer Cells in a PTEN-dependent Manner.

Inhibition of RAD54B Suppresses Proliferation and Promotes Apoptosis in Hepatoma Cells

Prolyl hydroxylase-2 inhibits liver tumor cell proliferation and cyclin D1 expression in a hydroxylase-dependent manner

Elevated Expression of Wwp2 in Human Lung Adenocarcinoma and Its Effect on Migration and Invasion

Albendazole Exerts an Anti-Hepatocellular Carcinoma Effect Through a WWOX-dependent Pathway.

LncRNA WWOX-AS1 Sponges Mir-20B-5p in Hepatocellular Carcinoma and Represses Its Progression by Upregulating WWOX

WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc

Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma